On July 6, 2023, Cable Car Capital LLC sent a letter to Forte Biosciences, Inc. containing a stockholder proposal under Rule 14a-8, for presentation to the Company?s stockholders at the Company?s 2023 annual meeting of stockholders, to terminate the Company?s Preferred Stock Rights Agreement, dated July 12, 2022, as amended on June 26, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5938 USD | -4.99% | +2.40% | -27.74% |
05-30 | Brookline Capital Initiates Forte Biosciences at Buy Rating With $4 Price Target | MT |
05-13 | Forte Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.74% | 21.61M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- FBRX Stock
- News Forte Biosciences, Inc.
- Cable Car Capital Submits a Shareholder Proposal to Forte Biosciences